Donald Trump is ramping up pressure on drug companies to be more transparent about the risks associated with their prescription products. In a memorandum signed on Tuesday, the President ordered ...
A new Trump administration crackdown on prescription drug ads directed at consumers could substantially drag on pharmaceutical revenues—if it’s successful at reining in the billions of dollars that ...
This article first appeared in the newsletter Your Local Epidemiologist. Pharmaceutical ads in the United States are annoying. Absurd. And almost uniquely American. In fact, only one other high-income ...
WASHINGTON (AP) — Health Secretary Robert F. Kennedy Jr. and other administration officials are vowing a crackdown on deceptive drug ads, but the effort is likely to face multiple headwinds, including ...
DTC Drug Ads: New Study Finds Perception of Risks Diluted by Lengthy Side Effects List A study on direct-to-consumer (DTC) drug advertising published Monday in Nature Human Behavior finds that ...
(The Conversation is an independent and nonprofit source of news, analysis and commentary from academic experts.) Anna Chorniy, Icahn School of Medicine at Mount Sinai; Institute for Humane Studies ...
Editor’s note: This article was updated on 12 September 2025 to correct a mischaracterization of the history of adequate provision concept in drug advertising ...
WASHINGTON (MarketWatch) - Hoping to head off tougher government regulation, the pharmaceutical industry on Tuesday unveiled new advertising guidelines that require drug makers to take time to educate ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results